Bulletin
Investor Alert

New York Markets Open in:

Market Snapshot Analyst Ratings

Marinus Pharmaceuticals Inc.

NAS: MRNS

GO

Set Alerts

Market Index

Overview Profile Charts Financials Historical Quotes Analyst Estimates Options SEC Filings Insiders
/marketstate/country/us
Marinus Pharmaceuticals Inc.

After Hours

MRNS
/zigman2/quotes/208112000/composite

$

6.30

Change

0.00 0.00%

Volume

Volume 5,896

Nov 27, 2023, 4:01 p.m.

Quotes are delayed by 20 min

/zigman2/quotes/208112000/composite

Previous close

$ 6.46

$ 6.30

Change

-0.16 -2.48%

Day low

Day high

$6.16

$6.40

Open
Open: 6.39

52 week low

52 week high

$3.47

$11.15

Open

Market cap

$352.55M

Average volume

539,072

P/E ratio

N/A

Rev. per Employee

$205,040

EPS

-2.65

Dividend

N/A

Div yield

N/A

Ex dividend date

N/A

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/mrns

MarketWatch News on MRNS

  1. Marinus Pharmaceuticals price target cut to $42 from $50 at Truist Financial

    9:27 a.m. May 12, 2023

    - Steve Gelsi

  3. Moderna's stock drops 6.3% to pace the S&P 500's premarket losers

    9:24 a.m. Jan. 24, 2022

    - Tomi Kilgore

  4. Marinus Pharmaceuticals initiated at buy with $35 price target at Truist Securities

    7:22 a.m. Sept. 30, 2020

    - Tonya Garcia

  5. Marinus Pharmaceuticals started at outperform with $6 stock price target at Oppenheimer

    7:31 a.m. Dec. 20, 2019

    - Tomi Kilgore

  6. Marinus Pharma stock price target cut to $6 from $7 at Leerink

    7:59 a.m. Dec. 12, 2019

    - Ciara Linnane

  7. Marinus Pharma reiterated as outperform at Leerink

    1:22 p.m. Dec. 9, 2019

    - Ciara Linnane

  8. 5 stocks trading at under $10 worth discovering

    11:46 a.m. June 27, 2019

    - Michael Brush

  9. Harry Boxer’s four health-care stocks to watch

    11:54 a.m. July 12, 2018

    - Harry Boxer

  12. Bain Makes Bank in Two Rebounding Biotechs

    7:58 a.m. Dec. 21, 2017

    - Barron's Online

  14. Marinus Pharma stock surges on positive mid-stage data for rare genetic disorder drug

    10:41 a.m. Jan. 23, 2017

    - Emma Court

  15. Marinus Pharma stock surges 45% to $1.69 per share

    10:39 a.m. Jan. 23, 2017

    - Emma Court

  16. Marinus Pharmaceuticals stock price target cut to $2 from $14 at RBC Capital

    6:42 a.m. June 14, 2016

    - Tomi Kilgore

  17. Marinus Pharmaceuticals downgraded to sector perform from market perform at RBC Capital

    6:42 a.m. June 14, 2016

    - Tomi Kilgore

  18. Marinus Pharmaceuticals shares down 58% in premarket trade

    7:03 a.m. June 13, 2016

    - Ciara Linnane

  20. Marinus Pharma shares halted in premarket trade

    6:37 a.m. June 13, 2016

    - Ciara Linnane

  21. Loading more headlines...

Analyst Ratings

/news/nonmarketwatch/company/us/mrns

Other News on MRNS

  1. 10-Q: MARINUS PHARMACEUTICALS, INC.

    7:03 a.m. May 11, 2023

    - Edgar Online - (EDG = 10Q, 10K)

  2. 10-K: MARINUS PHARMACEUTICALS, INC.

    4:06 p.m. March 9, 2023

    - Edgar Online - (EDG = 10Q, 10K)

/news/pressrelease/company/us/mrns

Press Releases on MRNS

  5. Marinus Pharmaceuticals to Present at Upcoming Investor Conferences

    6:01 a.m. May 3, 2023

    - BusinessWire - BZX

  14. Marinus Pharmaceuticals to Present at Upcoming Investor Conferences

    7:15 a.m. Feb. 7, 2023

    - BusinessWire - BZX

Rates »

Mortgage Equity Savings Auto
Link to MarketWatch's Slice.